Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2022 May 10;28:597. doi: 10.1016/j.omtn.2022.05.016

Retraction Notice to: LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270

Aimei Zou, Xingli Liu, Zongjiong Mai, Junke Zhang, Zhuohuan Liu, Qilu Huang, Aibing Wu , Chenyu Zhou ∗∗
PMCID: PMC9108530  PMID: 35614992

Main text

(Molecular Therapy: Nucleic Acids 17, 563–577; September 2019)

This article has been retracted at the request of the editors of Molecular Therapy – Nucleic Acids.

During an investigation, evidence for image duplication in identical or altered fashion in Figures 2C, 5B, and 6G was identified. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors did not respond when contacted about the retraction.

Contributor Information

Aibing Wu, Email: wab80106@163.com.

Chenyu Zhou, Email: zhouchengyu1966@21cn.com.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES